参考文献

1 Du r u k a n A, Ta t l i s uma k T. Ac u t e i s ch emi c

stroke:Overview of major experimental rodent

models, pathophysiology, and therapy of focal cerebral

ischemia[J]. Pharmacol Biochem Behav, 2007, 87:179-

197.

2 Macrae IM. Preclinical stroke research--advantages

and disadvantages of the most common rodent models

of focal ischaemia[J]. Br J Pharmacol, 2011, 164:1062-

1078.

3 del Zoppo GJ. Relevance of focal cerebral ischemia

models. Experience with fibrinolytic agents[J]. Stroke,

1990, 21:IV155-IV160.

4 Willing AE. Experimental models:Help or hindrance.

Stroke, 2009, 40:S152-S154.

5 Slikkker W, Youdim M, Palmer GC, et al. The future of

neuroprotection[J]. Ann N Y Acad Sci, 1999, 890:529-

533.

6 Richard Green A, Odergren T, Ashwood T. Animal

models of stroke:Do they have value for discovering

neuroprotective agents?[J]. Trends Pharmacol Sci, 2003,

24:402-408.

7 Saver JL, Albers GW, Dunn B,et al. STAIR VI

Consortium. Stroke Therapy Academic Industry

Roundtable (STAIR). Recommendations for standards

regarding preclinical neuroprotective and restorative

drug development[J]. Stroke, 1999, 30:2752-2758.

8 Fisher M, Feuerstein G, Howells DW, et al. Update

of the stroke therapy academic industry roundtable

preclinical recommendations[J]. Stroke, 2009, 40:2244-

2250.

9 Macleod MR, Fisher M, O'Collins V, et al. Good

laboratory practice:Preventing introduction of bias at

the bench[J]. Stroke, 2009, 40:e50-e52.

10 Fan X, Qiu J, Yu Z, et al. A rat model of studying

tissue-type plasminogen activator thrombolysis in

ischemic stroke with diabetes[J]. Stroke, 2012, 43:567-

570.

11 Liu S, Zhen G, Meloni BP, et al. Rodent stroke model

guidelines for preclinical stroke trials (1st edition)[J]. J

Exp Stroke Transl Med, 2009, 2:2-27.

12 Durukan A, Strbian D, Tatlisumak T. Rodent models

of ischemic stroke:A useful tool for stroke drug

development[J]. Curr Pharm Des, 2008, 14:359-370.

13 Harada H, Wang Y, Mishima Y, et al. A novel method

of detecting rcbf with laser-Doppler flow metry without

cranial window through the skull for a MCAO rat

model[J]. Brain Res Brain Res Protoc, 2005, 14:165-170.

14 Prieto R, Carceller F, Roda JM, et al. The intraluminal

thread model revisited:Rat strain differences in local

cerebral blood flow[J]. Neurol Res, 2005, 27:47-52.

15 Wang Q, Xu J, Rottinghaus GE, et al. Resveratrol

protects against global cerebral ischemic injury in gerbils[J]. Brain Res, 2002, 958:439-447.

16 Kohno K, Back T, Hoehn-Berlage M, et al. A modified

rat model of middle cerebral artery thread occlusion

under electrophysiological control for magnetic

resonance investigations[J]. Magn Reson Imaging,

1995, 13:65-71.

17 Huang L, Wang Y, Liu J, et al. Approximate entropy of

eeg as a measure of cerebral ischemic injury[J]. Conf

Proc IEEE Eng Med Biol Soc, 2004, 6:4537-4539.

18 Schaar KL, Brenneman MM, Savitz SI. Functional

assessments in the rodent stroke model[J]. Exp Transl

Stroke Med, 2010, 2:13.

19 Zarruk JG, Garcia-Yebenes I, Romera VG, et al.

Neurological tests for functional outcome assessment in

rodent models of ischaemic stroke[J]. Rev Neurol, 2011,

53:607-618.

20 Longa EZ, Weinstein PR, Carlson S, et al. Reversible

middle cerebral artery occlusion without craniectomy

in rats[J]. Stroke, 1989, 20:84-91.

21 Bederson JB, Pitts LH, Tsuji M, et al. Rat middle

cerebral artery occlusion:Evaluation of the model and

development of a neurologic examination[J]. Stroke,

1986, 17:472-476.

22 Roger s DC, Campbell CA, St ret ton JL, et al.

Correlation between motor impairment and infarct

volume after permanent and transient middle cerebral

artery occlusion in the rat[J]. Stroke, 1997, 28:2060-

2066.

23 D'Hooge R, De Deyn PP. Applications of the morris

water maze in the study of learning and memory[J].

Brain Res Brain Res Rev, 2001, 36:60-90.

24 Di n g Y, Z h o u Y, L a i Q, e t a l . L o n g - t e rm

neuroprotective effect of inhibiting poly(adp-ribose)

polymerase in rats with middle cerebral artery

occlusion using a behavioral assessment[J]. Brain Res,

2001, 915:210-217.

25 Bland ST, Schallert T, Strong R, et al. Early exclusive

use of the affected forelimb after moderate transient

focal ischemia in rats:Functional and anatomic

outcome[J]. Stroke, 2000, 31:1144-1152.

26 Zhen G, Dore S. Optimized protocol to reduce variable

outcomes for the bilateral common carotid artery

occlusion model in mice[J]. J Neurosci Methods, 2007,

166:73-80.

27 Bederson JB, Pitts LH, Germano SM, et al. Evaluation

of 2, 3, 5-triphenyltetrazolium chloride as a stain for

detection and quantification of experimental cerebral

infarction in rats[J]. Stroke, 1986, 17:1304-1308.

28 Gavins F, Yilmaz G, Granger DN. The evolving

paradigm for blood cell-endothelial cell interactions

in the cerebral microcirculation[J]. Microcirculation,

2007, 14:667-681.

29 Ishikawa M, Zhang JH, Nanda A, et al. Inflammatory

responses to ischemia and reperfusion in the cerebral

microcirculation[J]. Front Biosci, 2004, 9:1339-1347.

30 Wang Q, Kalogeris TJ, Wang M, et al. Antecedent

ethanol attenuates cerebral ischemia/reperfusioninduced

leukocyte-endothelial adhesive interactions

and delayed neuronal death:role of large conductance

Ca2+-actinated K+ channels[J]. Microcirculation, 2010,

17:427-438.

31 Gidday JM, Gasche YG, Copin JC, et al. Leukocytederived

matrix metalloproteinase-9 mediates bloodbrain

barrier breakdown and is proinflammatory after

transient focal cerebral ischemia[J]. Am J Physiol Heart

Circ Physiol, 2005, 289:H558-H568.

32 Yang G, Chan PH, Chen SF, et al. Reduction of

vasogenic edema and infarction by mk-801 in rats after

temporary focal cerebral ischemia[J]. Neurosurgery,

1994, 34:339-345.

33 Lin TN, Wang Q, Simonyi A, et al. Induction of

secretory phospholipase a2 in reactive astrocytes in

response to transient focal cerebral ischemia in the rat

brain[J]. J Neurochem, 2004, 90:637-645.

34 Garcia JH, Liu KF, Ho KL. Neuronal necrosis

after middle cerebral artery occlusion in Wistar

rats progresses at different time intervals in the

caudoputamen and the cortex[J]. Stroke, 1995, 26:636-

643.

35 Wang Q, Sun AY, Simonyi A, et al. Oral administration

of grape polyphenol extract ameliorates cerebral

ischemia/reperfusion-induced neuronal damage and

behavioral deficits in gerbils:Comparison of pre- and

post-ischemic administration[J]. J Nutr Biochem, 2009,

20:369-377.

36 Wang Q, Su n AY, Simonyi A, et al. Ethanol

preconditioning protects against ischemia/reperfusioninduced

brain damage:Role of NADPH oxidase-derived

ros[J]. Free Radic Biol Med, 2007, 43:1048-1060.

37 Sigler A, Murphy TH. In vivo 2-photon imaging of fine

structure in the rodent brain:Before, during, and after

stroke[J]. Stroke, 2010, 41:S117-S123.

38 Van Hemel r ijck A, Sar re S, Smolders I, et al.

Determination of amino acids associated with

cerebral ischaemia in rat brain microdialysates using

narrowbore liquid chromatography and fluorescence

detection[J]. J Neurosci Methods, 2005, 144:63-71.

39 Barone FC, White RF, Spera PA, et al. Ischemic

preconditioning and brain tolerance:Temporal

histological and functional outcomes, protein synthesis

requirement, and interleukin-1 receptor antagonist and

early gene expression[J]. Stroke, 1998, 29:1937-1950,discussion 1950-1931.

40 Datta A, Jingru Q, Khor TH, et al. Quantitative

neuroproteomics of an in vivo rodent model of focal

cerebral ischemia/reperfusion injury reveals a temporal

regulation of novel pathophysiological molecular

markers[J]. J Proteome Res, 2011, 10:5199-5213.

41 Iadecola C, Ross ME. Molecular pathology of cerebral

ischemia:Delayed gene expression and strategies for

neuroprotection[J]. Ann N Y Acad Sci, 1997, 835:203-

217.

42 Slevin M, Kr upinski J, Kuma r P, et al. Gene

activation and protein expression following ischaemic

stroke:Strategies towards neuroprotection[J]. J Cell Mol

Med, 2005, 9:85-102.

43 Stenzel-Poore MP, Stevens SL, Simon RP. Genomics of

preconditioning[J]. Stroke, 2004, 35:2683-2686.

44 Hoehn M, Nicolay K, Franke C, et al. Application

of magnetic resonance to animal models of cerebral

ischemia[J]. J Magn Reson Imaging, 2001, 14:491-509.

45 Sevick RJ, Kucharczyk J, Mintorovitch J, et al.

Diffusion-weighted MR imaging and T2-weighted MR

imaging in acute cerebral ischaemia:Comparison and

correlation with histopathology[J]. Acta Neurochir

Suppl (Wien), 1990, 51:210-212.

46 Tatlisumak T, Strbian D, Abo Ramadan U, et al. The

role of diffusion- and perfusion-weighted magnetic

resonance imaging in drug development for ischemic

stroke:From laboratory to clinics[J]. Curr Vasc

Pharmacol, 2004, 2:343-355.

47 Hoyte LC, Brooks KJ, Nagel S, et al. Molecular

magnetic resonance imaging of acute vascular cell

adhesion molecule-1 expression in a mouse model of

cerebral ischemia[J]. J Cereb Blood Flow Metab, 2010,

30:1178-1187.

48 McLeod DD, Parsons MW, Levi CR, et al. Establishing

a rodent stroke perfusion computed tomography

model[J]. Int J Stroke, 2011, 6:284-289.

49 Hayasaka N, Nagai N, Kawao N, et al. In vivo

diagnostic imaging using micro-CT:Sequential and

comparative evaluation of rodent models for hepatic/

brain ischemia and stroke[J]. PLoS One, 2012, 7:e32342.